Mehmet Ozturk - Google Scholar

Cited by

	All	Since 2015
Citations	10145	1970
h-index	45	23
i10-index	90	42

460

230

115

345

19881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202035 27 56 111 309 357 372 401 294 311 280 316 350 313 348 283 335 306 366 307 307 306 306 386 397 418 446 396 337 348 344 329 214

Co-authors

Jack Wandsprofessor of medicine,Brown UniversityVerified email at brown.edu
Rengul Cetin AtalayUniversity of Chicago and Middle East Technical UniversityVerified email at metu.edu.tr
Dominique BELLETProfesseur d'immunologie, Université Paris DescartesVerified email at parisdescartes.fr
Serif SenturkResearch Group Leader at Izmir Biomedicine and Genome CenterVerified email at ibg.edu.tr
Ozge gursoy YuzugulluDana Farber Cancer Institute, Harvard Medical SchoolVerified email at dfci.harvard.edu
Frederique PonchelThe University of Leeds (LIRMM, TRIMID)Verified email at leeds.ac.uk
YAKICIERProfessor of Molecular Biology and Genetics ACIBADEM UniversityVerified email at acibadem.com.tr
HALUK YUZUGULLUAstrazeneca PharmaceuticalsVerified email at astrazeneca.com
Hiroshi TakahashiTexas Instruments JapanVerified email at ti.com
Cigdem Ozen, Ph.D.Specialist at Izmir International Biomedicine and Genome Institute, iBG-izmir, Dokuz EylülVerified email at deu.edu.tr
Nuri OzturkProfessor @ Gebze Technical UniversityVerified email at gtu.edu.tr
Ayça Arslan ErgülStem Cell Center, Hacettepe UniversityVerified email at hacettepe.edu.tr
Tamer YagciVerified email at gyte.edu.tr
Gokhan YildizKaradeniz Technical University School of Medicine Department of Medical BiologyVerified email at ktu.edu.tr
Hilal Ozdag PhDAnkara University Biotechnology InstituteVerified email at ankara.edu.tr
Isik G. YulugAssociate Professor of Molecular Biology and Genetics, Bilkent UniversityVerified email at fen.bilkent.edu.tr
Bert VogelsteinJohns HopkinsVerified email at jhmi.edu
Tolga CagatayUT Southwestern Medical Center at DallasVerified email at utsouthwestern.edu
Berna S. SayanUniversity of ManchesterVerified email at manchester.ac.uk
Thierry soussiProfessor of Molecular BiologyVerified email at ki.se

Mehmet Ozturk

Izmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey

Verified email at deu.edu.tr - Homepage

Molecular Biology Genetics Cell Biology Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Selective G to T mutations of p 53 gene in hepatocellular carcinoma from southern Africa B Bressac, M Kew, J Wands, M Ozturk Nature 350 (6317), 429-431, 1991	1624	1991
p53 functions as a cell cycle control protein in osteosarcomas. L Diller, J Kassel, CE Nelson, MA Gryka, G Litwak, M Gebhardt, B Bressac, ... Molecular and cellular biology 10 (11), 5772-5781, 1990	948	1990
p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991	558	1991
P53 HOTSPOT MUTATION IN HEPATOCELLULAR-CARCINOMA IS LINKED TO AFLATOXIN EXPOSURE M Ozturk, B BRESSAC, A Puisieux, M Kew, M Volkmann, S Bozcali, ... HEPATOLOGY 14 (4), A94-A94, 1991	558*	1991
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma B Bressac, KM Galvin, TJ Liang, KJ Isselbacher, JR Wands, M Ozturk Proceedings of the National Academy of Sciences 87 (5), 1973-1977, 1990	506	1990
Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway JP Rouault, N Falette, F Guéhenneux, C Guillot, R Rimokh, Q Wang, ... Nature genetics 14 (4), 482-486, 1996	447	1996
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens A Puisieux, S Lim, J Groopman, M Ozturk Cancer research 51 (22), 6185-6189, 1991	358	1991
Human MLH1 deficiency predisposes to hematological maligancy and neurofibromatosis type 1 MD Ricciardone, T Özçelik, B Cevher, H Özdağ, M Tuncer, A Gürgey, ... Cancer research 59 (2), 290, 1999	267	1999
Systems medicine and integrated care to combat chronic noncommunicable diseases J Bousquet, JM Anto, PJ Sterk, IM Adcock, KF Chung, J Roca, A Agusti, ... Genome Medicine 3 (7), 1-12, 2011	257	2011
Genetic aspects of hepatocellular carcinogenesis. M Ozturk Seminars in liver disease 19 (3), 235-242, 1998	245	1998
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ... Molecular cancer 8 (1), 90, 2009	209	2009
Smad2 and Smad4 gene mutations in hepatocellular carcinoma MC Yakicier, MB Irmak, A Romano, M Kew, M Ozturk Oncogene 18 (34), 4879, 1999	208	1999
Genetic heterogeneity of hepatocellular carcinoma H Unsal, C Yakicier, C Marcais, M Kew, M Volkmann, H Zentgraf, ... Proceedings of the National Academy of Sciences 91 (2), 822-826, 1994	202	1994
PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways E Demir, O Babur, U Dogrusoz, A Gursoy, G Nisanci, R Cetin-Atalay, ... Bioinformatics 18 (7), 996-1003, 2002	194	2002
Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth S Senturk, M Mumcuoglu, O Gursoy‐Yuzugullu, B Cingoz, KC Akcali, ... Hepatology 52 (3), 966-974, 2010	179	2010
Evaluation of cytotoxicity and oxidative DNA damaging effects of di (2-ethylhexyl)-phthalate (DEHP) and mono (2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and … P Erkekoglu, W Rachidi, OG Yuzugullu, B Giray, A Favier, M Ozturk, ... Toxicology and applied pharmacology 248 (1), 52-62, 2010	174	2010
Redundant expression of canonical Wnt ligands in human breast cancer cell lines K Benhaj, KC Akcali, M Ozturk Oncology reports 15 (3), 701-707, 2006	169	2006
Physiological studies of human chorionic gonadotropin (hCG), αhCG, and βhCG as measured by specific monoclonal immunoradiometric assays M OZTURK, D BELLET, LUC MANIL, G HENNEN, R FRYDMAN, ... Endocrinology 120 (2), 549-558, 1987	156	1987
Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines A Puisieux, K Galvin, F Troalen, B Bressac, C Marcais, E Galun, ... The FASEB journal 7 (14), 1407-1413, 1993	155	1993
P53 mutation as a source of aberrant β-catenin accumulation in cancer cells T Cagatay, M Ozturk Oncogene 21 (52), 7971, 2002	113	2002

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Upload PDF

Follow this author

Cited by

Co-authors